PDGFRA and neoplasm: Although as one might expect, more mutations were detected in the tumor tissue, including MTOR and BRCA1; however, the pathogenic PDGFRA variant (c.1939A > G, p.Ile647Val) was found in the urinary exosomes from both UC and NanoPoms preparations, but not in the tumor tissue cells (Fig. 2b).